Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

Fang Liu, MD PhD, Hongyu Zhang, MD PhD, Xiao Wang, MD PhD, Yisong Xiong, PhD, Yuanzhen Cao, Yi Su, MD, Hai Yi, MD PhD, Jia Feng, MD PhD, Wenli Zhang, MD, Yu Ma, Masayuki Wada, PhD, Yupo Ma, MD PhD

Blood (2019) 134 (Supplement_1): 38.

https://doi.org/10.1182/blood-2019-122964

Published: 2019

Journal Articles

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Morie A. Gertz, MD MACP, Haiyan Qiu, PhD, Laura Kendall, Mario Saltarelli, MDPhD, Ted Yednock, PhD, Sethu Sankaranarayanan, PhD

Blood (2016) 128 (22): 1265.

https://doi.org/10.1182/blood.V128.22.1265.1265

Published: 2016

Journal Articles

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Adam Bryant, MD, Elizabeth Pringle, MD, Christopher Bredeson, MD MSc, FRCPC, David S. Allan, MD MSc, Grizel Anstee, Isabelle Bence-Bruckler, Linda Hamelin, Harry Spencer Hopkins, Lothar B. Huebsch, MD, Mitchell Sabloff, MDM, Dawn C. Sheppard, MDFRCPC,MSc, Jason Tay, MD MSc, Harold Atkins, MD

Blood (2014) 124 (21): 3996.

https://doi.org/10.1182/blood.V124.21.3996.3996

Published: 2014

Journal Articles

Generation and Functional Properties Of FVIII-Specific Human T Regulatory Cells: A Novel Approach Using Hemophilia A patient’s T Cell Receptors

Yongchan Kim, PhD, Yan Su, PhD, Robert J. Rossi, B.A., Ruth A. Ettinger, Ph.D., Kathleen P. Pratt, Ph.D., David William Scott, PhD, Ethan Shevach, MD

Blood (2013) 122 (21): 3568.

https://doi.org/10.1182/blood.V122.21.3568.3568

Published: 2013

Journal Articles

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

Christina S Lee, B.A., Allison Imahiyerobo, ANP-BC, Micha Thompson, B.A., Marina Izak Karaev, M.D., Waleed Ghanima, MD, PhD, James B Bussel, MD

Blood (2013) 122 (21): 2310.

https://doi.org/10.1182/blood.V122.21.2310.2310

Published: 2013

Journal Articles

Polymorphisms in TNFA and CTLA-4 Genes and the Risk of Heparin Induced Thrombocytopenia.

Dorothee Leroux, Claire Pouplard, PharmD, PhD, Benoit Guillet, MD, PhD, Beatrice Cosne, Marc Antoine May, MD, Yves Gruel, MD

Blood (2008) 112 (11): 3414.

https://doi.org/10.1182/blood.V112.11.3414.3414

Published: 2008

NARROW

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Generation and Functional Properties Of FVIII-Specific Human T Regulatory Cells: A Novel Approach Using Hemophilia A patient’s T Cell Receptors

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

Polymorphisms in TNFA and CTLA-4 Genes and the Risk of Heparin Induced Thrombocytopenia.

Email alerts

ASH Publications

American Society of Hematology

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience

Generation and Functional Properties Of FVIII-Specific Human T Regulatory Cells: A Novel Approach Using Hemophilia A patient’s T Cell Receptors

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

Polymorphisms in TNFA and CTLA-4 Genes and the Risk of Heparin Induced Thrombocytopenia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only